RSV

GSK halts RSV vaccine trials in pregnant women after pause
GSK halts RSV vaccine trials in pregnant women after pause
Pharmaforum
GSK
clinical trials
RSV
vaccines
pregnancy
Flag link:
Moderna begins late-stage study of RSV vaccine using mRNA technology
Moderna begins late-stage study of RSV vaccine using mRNA technology
Yahoo/Reuters
Moderna Therapeutics
vaccines
MRNA
RSV
Flag link:
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
Fierce Biotech
GSK
Pfizer
RSV
vaccines
clinical trials
Flag link:
J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT
J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT
Fierce Pharma
JNJ
vaccines
COVID-19
RSV
drug manufacturing
Flag link:
J&J squares up to Big Pharma rivals with extra RSV vaccine data
J&J squares up to Big Pharma rivals with extra RSV vaccine data
Fierce Biotech
JNJ
vaccines
RSV
Pfizer
GSK
Flag link:
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Fierce Pharma
Sanofi
vaccines
RSV
Flu
MRNA
pneumococcal disease
Flag link:
RSVVW 2021 – Pfizer gets maternal
RSVVW 2021 – Pfizer gets maternal
EP Vantage
Pfizer
RSV
vaccines
RSVpreF
RSVVW
Flag link:
Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine
Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine
Motley Fool
JNJ
RSV
vaccines
clinical trials
Flag link:
J&J heats up RSV race with new vaccine data
J&J heats up RSV race with new vaccine data
BioPharma Dive
JNJ
RSV
vaccines
clinical trials
Flag link:
Could This Be Pfizer's Next Blockbuster Vaccine?
Could This Be Pfizer's Next Blockbuster Vaccine?
Motley Fool
Pfizer
vaccines
RSV
RSVpreF
clinical trials
Flag link:
GSK, J&J and Pfizer vie for $10B RSV vaccine market, with Bavarian Nordic and Moderna hot on their trail
GSK, J&J and Pfizer vie for $10B RSV vaccine market, with Bavarian Nordic and Moderna hot on their trail
Endpoints
GSK
JNJ
Pfizer
Bavarian Nordic
Moderna Therapeutics
RSV
vaccines
Flag link:
Pfizer, marking fast research pace, starts key trial of RSV vaccine
Pfizer, marking fast research pace, starts key trial of RSV vaccine
BioPharma Dive
Pfizer
clinical trials
RSV
vaccines
Flag link:
Bavarian Nordic gets a vaccine booster
Bavarian Nordic gets a vaccine booster
EP Vantage
Bavarian Nordic
vaccines
RSV
MVA-BN RSV
Flag link:
Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too
Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too
MedCity News
IPOs
Icosavax
RSV
vaccines
Flag link:
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work
Fierce Biotech
Pfizer
RSV
vaccines
GSK
JNJ
clinical trials
Flag link:
Moderna plans triple vaccine targeting flu, COVID and RSV
Moderna plans triple vaccine targeting flu, COVID and RSV
Pharmaforum
Moderna Therapeutics
vaccines
COVID-19
Flu
RSV
Flag link:
Sanofi, AstraZeneca mark big leap toward filing of RSV drug in 2022, with safety data in hand to challenge Synagis
Sanofi, AstraZeneca mark big leap toward filing of RSV drug in 2022, with safety data in hand to challenge Synagis
Endpoints
Sanofi
AstraZeneca
RSV
clinical trials
nirsevimab
Synagis
Flag link:
AstraZeneca and Sanofi Announce Big Breakthrough With RSV Vaccine
AstraZeneca and Sanofi Announce Big Breakthrough With RSV Vaccine
BioSpace
AstraZeneca
Sanofi
vaccines
RSV
nirsevimab
clinical trials
Flag link:
Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot
Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot
Fierce Biotech
Moderna Therapeutics
vaccines
mRNA-1345
RSV
COVID-19
Flag link:
GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
Biopharma Reporter
GSK
vaccines
RSV
clinical trials
Flag link:

Pages